Intervention
atorvastatin
ClinicalTrials.gov intervention label
Clinical trials
19 shownA Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese SubjectsNCT05815680 · 2023-04-06
COMPLETEDInvestigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy SubjectsNCT02243098 · 2014-09-16
COMPLETEDAtorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver DiseaseNCT01720719 · 2013-05-01
UNKNOWNDiazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesNCT00973271 · 2011-03-01
WITHDRAWNStatin Therapy to Improve Atherosclerosis in HIV PatientsNCT00965185 · 2009-09-01
COMPLETEDShort-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac SurgeryNCT00791648 · 2009-07-01
COMPLETEDEffect of Statins on Asthma Control in Smokers With AsthmaNCT00463827 · 2007-08-01
COMPLETEDCerebral and Peripheral Perfusion Pilot StudyNCT00751907 · 2006-06-01
COMPLETEDEffect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pHNCT01518166 · 2006-05-01
COMPLETEDCharacteristic Study on Chinese Patients With Multiple SclerosisNCT00818103 · 2006-01-01
UNKNOWNEzetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)NCT00157924 · 2005-11-01
COMPLETEDDiagnosis and Therapy of Vulnerable Atherosclerotic PlaqueNCT00636766 · 2005-09-01
COMPLETEDStatin Therapy in Heart Failure: Potential Mechanisms of BenefitNCT00233480 · 2005-08-01
COMPLETEDComparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And DyslipidemiaNCT00174330 · 2005-05-01
COMPLETEDCARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis PatientsNCT00211939 · 2005-01-01
COMPLETEDA Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart DiseaseNCT00134264 · 2004-07-01
TERMINATEDA Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High CholesterolNCT00645424 · 2003-12-01
COMPLETEDThe Effect of Statin Use on Vascular Function in Hypertensive SubjectsNCT00181181 · 2003-05-01
TERMINATEDEffects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and CognitionNCT00522158
COMPLETEDCommon conditions
Cardiovascular Disease2Diabetes2Diabetes Mellitus2Healthy2Hypertension2Acute Kidney Injury1Acute Renal Failure1Alzheimer's Disease1Arteriosclerosis1Asthma1Atherosclerosis1Calcinosis1Carotid Atherosclerosis1Cognition1COPD1Coronary Disease1Delirium1Dyslipidemias1Fatty Liver1Heart Failure, Congestive1HIV1HIV Infections1Hypercholesterolemia1Hyperlipidemia1Hyperlipidemias1
Leading sponsors
Novo Nordisk A/S2Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2Aristotle University Of Thessaloniki1Baskent University1Essentialis, Inc.1Innovent Biologics (Suzhou) Co. Ltd.1Johns Hopkins University1Massachusetts General Hospital1Nabi Biopharmaceuticals1NHS Greater Clyde and Glasgow1Organon and Co1Pfizer1Sun Yat-sen University1University of California, Los Angeles1University of Wisconsin, Madison1
Trial status mix
COMPLETED14
TERMINATED2
UNKNOWN2
WITHDRAWN1
Phase mix
PHASE48
NA4
PHASE13
PHASE22
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.